HSF1-DBC1轴通过激活转移性转录程序驱动前列腺癌的进展
Sue Jin Moon1,2, Hwa Jin Kim1,2, Joung Eun Lim3
1Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Republic of Korea.
Experimental & molecular medicine
|October 1, 2025
概括
热冲击因子1 (HSF1) 驱动前列腺癌的转移. 它的核心调节器DBC1稳定HSF1,促进癌症的生长. 向HSF1-DBC1通路为转移性癌症提供了潜在的治疗策略.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 热冲击因子1 (HSF1) 是一个转录因子,对细胞应激反应和蛋白质稳定至关重要.
- 在癌症中,HSF1经常过度表达,促进了扩散,存活和转移.
- 在恶性瘤中,持续的HSF1激活及其同调剂的机制在很大程度上是未知的.
研究的目的:
- 研究HSF1在转移性割耐性前列腺癌 (mCRPC) 中的作用.
- 在mCRPC中识别和描述HSF1的关键相关调节剂.
- 探索针对mCRPC中的HSF1通路的治疗潜力.
主要方法:
- 分析HSF1转录程序和mCRPC细胞中的基因组占用.
- 通过分子测试确定DBC1作为HSF1的核心调节剂.
- 研究DBC1对HSF1活动,稳定性和基因表达的影响.
- 在mCRPC中,HSF1-DBC1表达与患者结果的相关性.
主要成果:
- HSF1高度激活,对于mCRPC细胞的转移性传播和生长至关重要.
- DBC1充当HSF1的积极调节者,增强其转录活性和染色体结合.
- 对于超强增强剂的形成和激活像MMP11.11这样的转移相关基因,DBC1是必需的.
- DBC1通过促进三元化和酸化,同时抑制无处不在化,稳定HSF1.
- DBC1损失抑制了mCRPC转移,高的HSF1-DBC1表达预测了患者的不良结果.
结论:
- HSF1在促进前列腺癌转移方面发挥着至关重要的作用.
- DBC1是HSF1活动和mCRPC稳定的新型关键调节器.
- HSF1-DBC1轴代表了转移性前列腺癌的一个有前途的治疗标.
相关概念视频
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
MAPK Signaling Cascades
7.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.9K
The Ras Gene
7.0K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.0K


